Preclinical studies have indeed established that angptl2 induces vascular inflammation, including in endothelial cells and promote atherosclerosis [17, 18, 20]; however, its contribution to the development of chronic endothelial/vascular inflammation leading to endothelial dysfunction is less understood. The gene discussed is ANGPTL2; the disease is atherosclerosis.